CLIENT SUCCESSES

ondisplay

DestinationRx, Inc.: Venture Financing and Merger

DestinationRx, Inc. (DRX) is a Los Angeles-based leading provider of technology solutions for web-based prescription drug companies as well as Medicare health plan comparison and enrollment services. DRX’s clients include federal and local governments and some of the largest health plans in the United States. DRX was a privately-held, venture backed company.

In 2008, DRX undertook a venture capital led Series A financing and asked Maslon’s Doug Holod to serve as their corporate counsel. Since that time, Doug has led a team of Maslon attorneys, including Alan Gilbert, Shauro Bagchi, and Kathleen Crowe, to provide corporate governance, contract, securities and compensation, employment, insurance-related, litigation, other technology, trademark, and real estate services to DRX.

Working with a major health care investment banking firm, Doug led the legal team involved with DestinationRX’s merger with another health care technology company that closed in early 2013. While the terms of the transaction cannot be publically disclosed, the Maslon team worked on negotiating all legal aspects of the transaction such as the Letter of Intent, the Merger Agreement and related agreements.

DISCLAIMER
Thank you for your interest in contacting us by email.

Please do not submit any confidential information to Maslon via email on this website. By communicating with us we are not establishing an attorney-client relationship, and information you submit will not be protected by the attorney-client privilege and cannot be treated as confidential. A client relationship will not be formed until we have entered into a formal agreement. You should also be aware that we may currently represent parties whose interests may be adverse to yours, and we reserve the right to continue to represent them notwithstanding any communication we receive from you.

If you would like to discuss possible representation, please call one of our attorneys directly or use our general line (p 612.672.8200). We can then fully discuss our intake procedures and, if appropriate, introduce you to an attorney suited to assist with your matter. Alternatively, you may send us an email containing a general inquiry subject to these terms.

If you accept the terms of this notice and would like to send an email, click on the "Accept" button below. Otherwise, please click "Decline."